


| Key | % Net Assets |
|---|---|
| 2.9% | |
| 2.7% | |
| 2.6% | |
| 2.5% | |
| 89.3% |
| Name | % Net Assets |
|---|---|
| Microsoft | 2.9% |
| Covidien | 2.7% |
| Pfizer | 2.6% |
| General Electric | 2.5% |
| Apple | 2.4% |
| Comcast | 2.4% |
| Exelon | 2.4% |
| Chevron | 2.3% |
| PepsiCo | 2.2% |
| Morgan Stanley | 2.0% |
No asset data available.
| Date | 20-Sep-2019 |
|---|---|
| NAV | 252.19p |
| Currency | GBP |
| Change | -1.34p |
| % | -0.53% |
| YTD change | 252.19p |
| YTD % | n/a |
| Fund Inception | 14/10/2002 |
|---|---|
| Fund Manager | Tom Digenan |
| TER | 1.18 (31-Jan-2014) |
| Minimum Investment | |
|---|---|
| Initial | £100000 |
| Additional | £500 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | -0.03 |
You are here: research